Compugen Ltd.
Utility Patent Applications
Last updated:
List of all Compugen Ltd. patents 15 in total
Status | Patent |
---|---|
Application | Utility: ANTI-PVRIG ANTIBODIES FORMULATIONS AND USES THEREOF Filling date: 26 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: COMBINATIONS OF ANTI-ILDR2 ANTIBODIES AND PD-1 ANTAGONISTS Filling date: 26 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER Filling date: 26 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: POLYPEPTIDES AND USES THEREOF FOR TREATMENT OF AUTOIMMUNE DISORDERS AND INFECTION Filling date: 26 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: ANTI-PVRIG ANTIBODIES AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF Filling date: 26 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: PVRIG POLYPEPTIDES AND METHODS OF TREATMENT Filling date: 26 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: ILDR2 ANTAGONISTS AND COMBINATIONS THEREOF Filling date: 26 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: ANTI-VSIG10 ANTIBODIES AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: ANTI-PVRIG ANTIBODIES AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER Filling date: 26 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: ANTI-PVRIG/ANTI-TIGIT BISPECIFIC ANTIBODIES AND METHODS OF USE Filling date: 26 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF AUTOIMMUNE DISORDERS Filling date: 26 Sep 2025 Issue date: 10 Oct 2019 |
Application | Utility: POLYPEPTIDES AND USES THEREOF FOR TREATMENT OF AUTOIMMUNE DISORDERS AND INFECTION Filling date: 26 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISORDERS Filling date: 26 Sep 2025 Issue date: 1 Aug 2019 |
Showing 1 to 15 of 15 patents.